[ Price : $8.95]
Law firms Hogan Lovells and Foley and Lardner advise pharmaceutical and medical device companies to maintain full inspection readi...[ Price : $8.95]
Former FDA commissioner Andrew C. von Eschenbach and former HHS secretary Tommy G. Thompson urge policymakers to prioritize leader...[ Price : $8.95]
A new policy report urges sweeping FDA reforms, arguing that shortening the time required to bring drugs, biologics and medical de...[ Price : $8.95]
FDA and the drug industry conclude technical negotiations over the next iteration of the Prescription Drug User Fee Act, setting t...[ Price : $8.95]
An FDA crackdown on allegedly deceptive prescription drug advertising leads to a sharp increase in pharmaceutical advertising spen...[ Price : $8.95]
FDA posts a draft guidance that proposes streamlined nonclinical safety testing approaches for certain oncology biologics and conj...[ Price : $8.95]
ICH updates its long-running question-and-answer guidance tied to the ICH Q8, Q9 and Q10 pharmaceutical quality guidelines.[ Price : $8.95]
FDA issues BPI Labs a Form-483 following an April inspection for potential cross-contamination risks at its outsourcing facility i...